Thrivent Financial for Lutherans Reduces Stock Position in Trupanion, Inc. (NASDAQ:TRUP)

Thrivent Financial for Lutherans cut its holdings in Trupanion, Inc. (NASDAQ:TRUP) by 12.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,158 shares of the financial services provider’s stock after selling 3,841 shares during the period. Thrivent Financial for Lutherans’ holdings in Trupanion were worth $1,098,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. GAMMA Investing LLC raised its position in shares of Trupanion by 70.4% during the 3rd quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock worth $61,000 after acquiring an additional 596 shares in the last quarter. Headlands Technologies LLC purchased a new position in Trupanion in the second quarter valued at approximately $162,000. Entropy Technologies LP acquired a new stake in Trupanion during the third quarter worth approximately $202,000. Mutual of America Capital Management LLC purchased a new stake in shares of Trupanion during the 3rd quarter worth approximately $210,000. Finally, Oppenheimer Asset Management Inc. acquired a new position in shares of Trupanion in the 2nd quarter valued at $235,000.

Trupanion Trading Down 0.4 %

Shares of Trupanion stock opened at $53.31 on Monday. The firm has a market cap of $2.26 billion, a PE ratio of -166.59 and a beta of 1.69. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.40. Trupanion, Inc. has a fifty-two week low of $19.69 and a fifty-two week high of $57.90. The business’s fifty day moving average is $49.94 and its two-hundred day moving average is $40.37.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $0.03 EPS for the quarter, topping the consensus estimate of ($0.06) by $0.09. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. The firm had revenue of $327.50 million during the quarter, compared to analyst estimates of $321.79 million. During the same quarter in the prior year, the business posted ($0.10) earnings per share. Trupanion’s revenue for the quarter was up 14.6% compared to the same quarter last year. Analysts anticipate that Trupanion, Inc. will post -0.23 earnings per share for the current year.

Wall Street Analyst Weigh In

TRUP has been the topic of a number of research analyst reports. Evercore ISI upgraded Trupanion to a “strong-buy” rating in a research report on Friday, August 9th. Bank of America increased their price objective on Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a report on Friday, September 20th. Northland Securities upped their price target on shares of Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research report on Thursday, October 31st. Stifel Nicolaus raised their price objective on shares of Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a research report on Monday, September 23rd. Finally, Piper Sandler increased their target price on shares of Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a research note on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $44.67.

Insiders Place Their Bets

In other news, Director Murray B. Low sold 2,000 shares of the company’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $52.67, for a total value of $105,340.00. Following the completion of the transaction, the director now directly owns 131,513 shares in the company, valued at approximately $6,926,789.71. This represents a 1.50 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Steve Weinrauch sold 11,916 shares of the firm’s stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $53.00, for a total transaction of $631,548.00. Following the sale, the executive vice president now directly owns 48,978 shares of the company’s stock, valued at approximately $2,595,834. The trade was a 19.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 18,538 shares of company stock worth $988,741 over the last ninety days. 5.50% of the stock is owned by company insiders.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.